Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 11/12/2019.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques importées :
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | CERTICAN | EVEROLIMUS | 0,5 MG | COMPRIME | b/60 | NOVARTIS PHARMA | V | N | 13/05/2019 |
2 | SIMULECT | BASILIXIMAB | 20 MG | PDRE P PREP INJ | B/1F + S /5ML | NOVARTIS PHARMA | V | T | CS 16/05/2019 |
3 | ASPEGIC | ACETYL SALICYLATE DE LYSINE | 500 MG | PDRE PPREP INJ | B/20 FL | SANOFI AVENTIS | E | V | CS 16/05/2019 |
4 | ASPEGIC | ACETYL SALICYLATE DE LYSINE | 500 MG | PDRE PPREP INJ | B/6 FL | SANOFI AVENTIS | E | V | CS 16/05/2019 |
5 | OXYNORM | OXYCODONE (HCL) | 10 MG | SOL INJ | B/5 AMP/1ML | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2020 |
6 | OXYNORM | OXYCODONE (HCL) | 20 MG | SOL INJ | B/5 AMP/2ML | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2021 |
7 | OXYCONTIN | OXYCODONE (HCL) | 80 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2022 |
8 | OXYCONTIN | OXYCODONE (HCL) | 10 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2023 |
9 | OXYCONTIN | OXYCODONE (HCL) | 15 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2024 |
10 | OXYCONTIN | OXYCODONE (HCL) | 20 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2025 |
11 | OXYCONTIN | OXYCODONE (HCL) | 30 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2026 |
12 | OXYCONTIN | OXYCODONE (HCL) | 40 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2027 |
13 | OXYCONTIN | OXYCODONE (HCL) | 60 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2028 |
14 | BUTRANS | BUPRENORPHINE | 5µG/H | PATCHS TRANSDERMIQUE | B/4 PATCHS | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2029 |
15 | BUTRANS | BUPRENORPHINE | 10µG/H | PATCHS TRANSDERMIQUE | B/4 PATCHS | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2030 |
16 | BUTRANS | BUPRENORPHINE | 20µG/H | PATCHS TRANSDERMIQUE | B/4 PATCHS | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2031 |
17 | LEUPRO SANDOZ | LEUPRORELINE | 3,6MG | SERINGUE PRE REMPL | B/01 | SANDOZ PHARMA | V | N | 09/06/2019 |
18 | LEUPRO SANDOZ | LEUPRORELINE | 5 MG | SERINGUE PRE REMPL | B/01 | SANDOZ PHARMA | V | N | 09/06/2019 |
19 | GRANOCYTE | LENOGRASTIM | 34MUI/ML | POUDRE ET SOLVANT POUR SOLUTION INJECTABLE | B/05 | SANOFI | V | N | 19/06/2019 |
20 | AERIUS | DESLORATADINE | 5 MG | COMP PELLICULE | B/15 | Merck Sharp & Dohme Ltd R.U | E | N | 20/06/2019 |
21 | CANCIDAS | CASPOFUNGINE | 50 MG | PDRE P PREP INJ | B/01 | MERCK SHARP &DOHME BV | E | N | 21/06/2019 |
22 | CANCIDAS | CASPOFUNGINE | 70 MG | PDRE P PREP INJ | B/01 | MERCK SHARP &DOHME BV | E | N | 21/06/2019 |
23 | VFEND | VORICONAZOLE | 200MG | PDRE PR SOL PERFUSION | B/1 | PFIZER EUROPE | E | N | TRANSFERT 27/06/2019 |
24 | XALAtAN | LATANOPROST | 50µG/ML | COLLYRE | B/3FL2,5ML | PFIZER HOLDING | E | V | CS 09/07/2019 |
25 | XALAtAN | LATANOPROST | 50µG/MG | COLLYRE | B/1/FL2,5ML | PFIZER HOLDING | E | V | CS 09/07/2019 |
26 | XALACOM | LATANOPROST+ TIMOLOL | 50µG/5MG | COLLYRE | FL/1FL | PFIZER HOLDING | E | V | CS 09/07/2019 |
27 | XALACOM | LATANOPROST+ TIMOLOL | 50µG/5ML | COLLYRE | B/3F | PFIZER HOLDING | E | V | CS 09/07/2019 |
28 | TOBRADEX | DEXAMETHASONE +TOBRAMYCINE | 100 MG/300MG | COLLYRE | B/1F | NOVARTIS | E | N | CS 09/07/2019 |
29 | DAISYNELLE | DESOGESTREL+ ETHINYLOESTRADIOL | 150/20µG | COMPRIME | B/21 | STRAGEN | E | N | 18/07/2019 |
30 | ARNICA COMPLEXE N01 | ARNICA | SOL BUVABLE EN GOUTTES | FL/30ML | LEHNING | C | N | 18/07/2019 | |
31 | ADOL | PARACETAMOL | 100MG/ML | GOUTTES BUVABLES | FL/15ML | JULPHAR | E | V | 18/07/2019 |
32 | STOCRIN | EFAVIRENZ | 600 mg cp pell FL/630 | SOL BUV | B/1FL/180 ml | MERCK SHARP &DOHME BV | E | N | TRANSFERT 22/07/2019 |
33 | Cyclogest | Progesterone | 200 mg | Suppositoires | B/15 | ld Collins UK | N/T | 22/07/20219 | |
34 | OCREVUS | OCRELIZUMAB | 300 MG | SOL INJ PERF | B/1FL/10ML | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 29/07/2019 |
35 | GENSULIN R | INSULINE HUMAINE | 100UI/ML | SOL INJ | B/5Cartouches/3ML | BIOTON S.A | V | N | 29/07/2019 |
36 | GENSULIN M30 (30/70) | INSULINE HUMAINE | 100UI/ML | SUSP INJ | B/5Cartouches/3ML | BIOTON S.A | V | N | 29/07/2019 |
37 | GENSULIN N | INSULINE HUMAINE | 100UI/ML | SUSP INJ | B/5Cartouches/3ML | BIOTON S.A | V | N | 29/07/2019 |
38 | BENMAK | CHLORHYDRATE DE BENDAMUSTINE | 25 MG (2.5mg/ml) | pdre pr sol perf | B/5FL/10ML | MAKPHARM D.O.O | E | N | 30/07/2019 |
39 | BENMAK | CHLORHYDRATE DE BENDAMUSTINE | 100 MG (2.5mg/ml) | pdre pr sol perf | B/5FL/40ML | MAKPHARM D.O.O | E | N | 30/07/2019 |
40 | SEVOFLURANE USP | SEVOFLURANE | liquide pr inhalation | B/1FL/250ML | PIRAMAL CRITICAL CARE INC | V | N | 30/07/2019 | |
41 | AERIUS | DESLORATADINE | 5 MG | SIROP | B/1 | Merck Sharp & Dohme Ltd R.U | E | N | 16/08/2019 |
42 | REVLIMID | LENALIDOMIDE | 15 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
43 | REVLIMID | LENALIDOMIDE | 10 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
44 | REVLIMID | LENALIDOMIDE | 25 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
45 | REVLIMID | LENALIDOMIDE | 5 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
46 | ZINFORO | CEFTAROLINE FOSAMIL | 600 MG | PDRE PR SOL PERFUSION | B/10F | PFIZER Ireland Pharmaceuticals | E | N | TRANSFERT 27/08/2019 |
47 | GONAL F PEN | FOLLITROPINE | 900 UI/1.5 ml | SOL INJ | B/1stylo pré-rempli/1.5 ml +20 auig | MERCK EUROPE B.V | E | N | 29/08/2019 TRANSFERT AVEC VARIATION |
48 | GONAL F PEN | FOLLITROPINE | 450 UI/0,75 ml | SOL INJ | B/1stylo pré-rempli/1.5 ml +12 auig | MERCK EUROPE B.V | E | N | 29/08/2019 TRANSFERT AVEC VARIATION |
49 | GONAL F PEN | FOLLITROPINE | 300 UI/0,5 ml | SOL INJ | B/1stylo pré-rempli/1.5 ml +8 auig | MERCK EUROPE B.V | E | N | 29/08/2019 TRANSFERT AVEC VARIATION |
50 | CEBESINE | OXYBUPROCAINE | 0.4% | COLLYRE | FL/5ML | CHAUVIN | I | N | 03/09/2019 Extention de présentation avec changement d cond I |
51 | VFEND | VORICONAZOLE | 40 MG/ML | PDRE PR SUSP ORALE | B/1FL DE45G | PFIZER EUROPE MA EEIG | E | N | TRANSFERT 05/09/2019 |
52 | RAPAMUNE | SIROLIMUS | 1 MG | COMP ENROBE | B/30 | PFIZER S.A BELGIQUE | E | N | TRANSFERT 16/09/2019 |
53 | VFEND | VORICONAZOLE | 200MG | COMP PELLICULE | B/14 | PFIZER EUROPE MA EEIG | E | N | TRANSFERT 19/09/2019 |
54 | VFEND | VORICONAZOLE | 50 MG | COMP PELLICULE | B/28 | PFIZER EUROPE MA EEIG | E | N | TRANSFERT 19/09/2019 |
55 | DIAMOX 250 MG | ACETAZOLAMIDE | 250 mg | COMP | B/24 | COOPERATION PHARMACEUTIQUE FRANCAISE | E | N | TRANSFERT 09/10/2019 |
56 | SUTENT | SUNITINIB | 12.5 mg | GELULE | B/28 | PFIZER Europe MA EEIG | E | N | Transfert 29/10/2019 |
57 | SUTENT | SUNITINIB | 25 mg | GELULE | B/28 | PFIZER Europe MA EEIG | E | N | Transfert 29/10/2019 |
58 | SUTENT | SUNITINIB | 50 mg | GELULE | B/28 | PFIZER Europe MA EEIG | E | N | Transfert 29/10/2019 |
59 | DYNASTAT | PARECOXIB | 40MG | PDRE PR SOL INJ | B/10F | PFIZER Europe MA EEIG | E | N | TRANSFERET 29/10/2019 |
60 | TEMOZOLOMIDE ACCORD | TÉMOZOLOMIDE | 5 mg | GELULE | B/5 | ACCORD HEALTHCARE LTD | E | N | 01/11/2019 |
61 | TEMOZOLOMIDE ACCORD | TÉMOZOLOMIDE | 250 mg | GELULE | B/5 | ACCORD HEALTHCARE LTD | E | N | 01/11/2019 |
62 | TEMOZOLOMIDE ACCORD | TÉMOZOLOMIDE | 20 mg | GELULE | B/5 | ACCORD HEALTHCARE LTD | E | N | 01/11/2019 |
63 | TEMOZOLOMIDE ACCORD | TÉMOZOLOMIDE | 100 mg | GELULE | B/5 | ACCORD HEALTHCARE LTD | E | N | 01/11/2019 |
64 | SOOLANTRA | IVERMECTINE | 10mg/gr | CREME DERMIQUE | B/1tube de 15gr | GALDERMA INTERNATIONAL | C | N | 11/11/2019 |
65 | SERESTA | OXAZEPAM | 50 MG | COMP | B/20 | BIODIM | I | N | 11/11/2019 |
66 | SERESTA | OXAZEPAM | 10 MG | COMP | B/30 | BIODIM | I | N | 11/11/2019 |
67 | ELIQUIS | APIXABAN | 2.5 mg | COMP PELLICULE | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT 12/11/2019 |
68 | ELIQUIS | APIXABAN | 2.5 mg | COMP PELLICULE | B/60 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT 12/11/2019 |
69 | ELIQUIS | APIXABAN | 5 mg | COMP PELLICULE | B/60 | Bristol-Myers Squibb/Pfizr EEIG | E | N | 12/11/2019 |
70 | ELIQUIS | APIXABAN | 5 mg | COMP PELLICULE | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | 12/11/2019 |
71 | TOBRADEX | DEXAMETHASONE+TOBRAMYCINE | Tube/3.5 gr | pommade ophtalmo | Tube | NOVARTIS PHARMA SCHWEIZ AG | E | N | Transfert avec variation 14/11/2019 |
72 | REBIF | INTERFERON BETA-1A | 12 MUI/0.5 ml | SERINGUE PRE REMPL | B/12 seringues/0.5ML | MERCK EUROPE B.V | E | N | TRANSFERT 15 /11/2019 |
73 | ULTRA-LEVURE | SACCHAROMYCES BOULARDII | 200 mg | GELULE | FL/30 | BIOCODEX | I | N | 18/11/2019 |
74 | BRINTELLIX | VORTIOXETINE | 10 MG | COMP PELLICULE | B/28 | H.LUNDBECK A/S | E | N | CS 25/11/2019 |
75 | ZELDOX | ZIPRASIDONE | 20 MG/ML | PDRE PR PREP INJ | B/1FL+S/1,2ML | PFIZER GMbH | E | V | CS 25/11/2019 |
76 | ABILIFY | ARIPIPRAZOLE | 15 MG | COMP | B/28 | ABDI IBRAHIM OTSUKA | E | V | CS 25/11/2019 |
77 | ABILIFY | ARIPIPRAZOLE | 10 MG | COMP | B/28 | ABDI IBRAHIM OTSUKA | E | V | CS 25/11/2019 |
78 | UTROGESTAN | PROGESTERONE | 100 MG | CAPSULE MOLLE | B/30 | BESINS INT | E | V | CS 26/11/2019 |
79 | RHOPHYLAC | IMMUNOGLOBUNE HUMAINE ANTI D | 300µG/2ML | SERINGUE PRE REMPL | B/1 | CSL BEHRINGER | E | V | CS 26/11/2019 |
80 | CRESTOR | ROSUVASTATINE | 5 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
81 | CRESTOR | ROSUVASTATINE | 20 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
82 | CRESTOR | ROSUVASTATINE | 10 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
83 | TRESIBA | INSULINE DEGLUDEG | 200 UI/ML | SOL INJ | B/3 | NOVO NORDISK | V | V | CS 26/11/2019 |
84 | TRESIBA FLEXTOUCH | INSULINE DEGLUDEG | 100 UI/ML | SOL INJ | B/5 | NOVO NORDISK | V | V | CS 26/11/2019 |
85 | XELJANZ | TOFACITINIB | 5 MG | COMP PELLICULE | B/60 | PF PRISM C,V C/O PFIZER NETHERLANDS | E | V | CS 26/11/2019 |
86 | IMMUNORHO | IMMUNOGLOBUNE HUMAINE ANTI D | 300µG | PDRE PR PREP INJ | B/1FL | KEDRION S.P.A | E | V | CS 26/11/2019 |
87 | COMBIVIR | LAMIVUDINE+ZIDOVUDINE | 150mg/300mg | COMP PELLICULE SECABLE | B/60 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
88 | EPIVIR | LAMIVUDINE | 150 mg | COMP PELLICULE SECABLE | FL/60 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
89 | RETROVIR | ZIDOVUDINE | 100 mg | GELULE | B/100 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
90 | TOBREX | TOBRAMYCINE | 0.3% | COLLYRE | FL/5ML | NOVARTIS PHARMA AG (Bâle Suisse) | E | V | TRANSFERT avec variation 27/11/2019 |